1. Home
  2. MRUS vs DFH Comparison

MRUS vs DFH Comparison

Compare MRUS & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • DFH
  • Stock Information
  • Founded
  • MRUS 2003
  • DFH 2008
  • Country
  • MRUS Netherlands
  • DFH United States
  • Employees
  • MRUS N/A
  • DFH N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • DFH Homebuilding
  • Sector
  • MRUS Health Care
  • DFH Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • DFH Nasdaq
  • Market Cap
  • MRUS 2.9B
  • DFH 3.1B
  • IPO Year
  • MRUS 2016
  • DFH 2021
  • Fundamental
  • Price
  • MRUS $43.92
  • DFH $26.82
  • Analyst Decision
  • MRUS Strong Buy
  • DFH Hold
  • Analyst Count
  • MRUS 12
  • DFH 1
  • Target Price
  • MRUS $87.92
  • DFH $38.00
  • AVG Volume (30 Days)
  • MRUS 635.1K
  • DFH 885.6K
  • Earning Date
  • MRUS 10-31-2024
  • DFH 10-31-2024
  • Dividend Yield
  • MRUS N/A
  • DFH N/A
  • EPS Growth
  • MRUS N/A
  • DFH 15.80
  • EPS
  • MRUS N/A
  • DFH 3.03
  • Revenue
  • MRUS $35,932,000.00
  • DFH $4,028,851,000.00
  • Revenue This Year
  • MRUS N/A
  • DFH $15.83
  • Revenue Next Year
  • MRUS $57.37
  • DFH N/A
  • P/E Ratio
  • MRUS N/A
  • DFH $8.94
  • Revenue Growth
  • MRUS N/A
  • DFH 8.59
  • 52 Week Low
  • MRUS $24.95
  • DFH $23.46
  • 52 Week High
  • MRUS $61.61
  • DFH $44.38
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 43.33
  • DFH 32.01
  • Support Level
  • MRUS $41.03
  • DFH $26.89
  • Resistance Level
  • MRUS $43.68
  • DFH $30.71
  • Average True Range (ATR)
  • MRUS 2.28
  • DFH 1.17
  • MACD
  • MRUS 0.14
  • DFH -0.47
  • Stochastic Oscillator
  • MRUS 29.61
  • DFH 3.45

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.

Share on Social Networks: